# VV Manager LLC

> Institutional holdings reported to the SEC as of Q2 2020 on Form 13F. CIK 1735804. Source: https://holderbook.com/funds/1735804-vv-manager-llc/

- Reported value: $114.0M
- Positions: 4
- Weight of the ten largest: 100.0%
- Filed: 2020-08-04

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| ALLOGENE THERAPEUTICS INC | [ALLO](https://holderbook.com/stocks/ALLO/) | $77.0M | 1,798,163 | 67.5% | 7 |
| OYSTER POINT PHARMA, INC. | - | $22.5M | 778,468 | 19.7% | 2 |
| HOMOLOGY MEDICINES INC | [FIXX](https://holderbook.com/stocks/FIXX/) | $11.7M | 770,845 | 10.3% | 7 |
| SUTRO BIOPHARMA INC | [STRO](https://holderbook.com/stocks/STRO/) | $2.8M | 365,656 | 2.5% | 7 |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q2 2020 | $114.0M | 4 |
| Q1 2020 | $88.5M | 4 |
| Q4 2019 | $125.5M | 4 |
| Q3 2019 | $134.4M | 3 |
| Q2 2019 | $184.4M | 3 |
| Q1 2019 | $254.8M | 3 |
| Q4 2018 | $233.1M | 3 |